# Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors

> **NCT06107608** · NA · RECRUITING · sponsor: **Jules Bordet Institute** · enrollment: 58 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** FAPI PET/CT

## Key facts

- **NCT ID:** NCT06107608
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-13
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107608, "Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06107608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*